🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Edward A. Motea

Indiana University Health

ORCID: 0000-0001-5748-9466

Also affiliated with University of Indianapolis, Indiana Cancer Consortium, Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indiana University School of Medicine, Indiana University – Purdue University Indianapolis, Indiana University

Biochemistry, Genetics and Molecular BiologyMedicinePharmacology, Toxicology and Pharmaceutics

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 9 papers. Top paper: “Leveraging an NQO1 Bioactivatable Drug for Tumor-Selective Use of Poly(ADP-ribose) Polymerase Inhibitors”.

Leveraging an NQO1 Bioactivatable Drug for Tumor-Selective Use of Poly(ADP-ribose) Polymerase Inhibitors

Cancer Cell(2016)10.1016/j.ccell.2016.11.006
N/A
0.735DataRank · unranked
133 citations

Edward A. Motea, Zachary R. Moore, Jun Yao, Ying Dong, Gaurab Chakrabarti +19 more

XRN2 interactome reveals its synthetic lethal relationship with PARP1 inhibition

Scientific Reports(2020)10.1038/s41598-020-71203-7
N/A
0.416DataRank · unranked
15 citations

Talysa Viera, Julio C. Morales, Naveen Singh, Edward A. Motea, Megha Khandelwal +2 more

Therapeutic Strategies and Biomarkers to Modulate PARP Activity for Targeted Cancer Therapy

Cancers(2020)10.3390/cancers12040972
N/A
0DataRank · unranked
27 citations

S. Louise Pay, Snehal B. Bhandare, Udhaya Arimpur, Edward A. Motea, Naveen Singh

Targeting Base Excision Repair in Cancer: NQO1-Bioactivatable Drugs Improve Tumor Selectivity and Reduce Treatment Toxicity Through Radiosensitization of Human Cancer

Frontiers in Oncology(2020)10.3389/fonc.2020.01575
N/A
0DataRank · unranked
20 citations

S. Louise Pay, Naveen Singh, I‐Ju Yeh, Snehal B. Bhandare, Xiaolin Su +5 more

Detecting Attomolar DNA-Damaging Anticancer Drug Activity in Cell Lysates with Electrochemical DNA Devices

ACS Sensors(2021)10.1021/acssensors.1c00365
N/A
0DataRank · unranked
7 citations

Naveen Singh, Colton L. Starcher, Chloe C. DiTusa, Zakari Ishak-Boushaki, Dimithree Kahanda +4 more

cMET inhibition potentiates the tumor‐selective damaging effects of NQO1‐bioactivatable agents by compromising DNA repair

The FASEB Journal(2022)10.1096/fasebj.2022.36.s1.r4326
N/A
0DataRank · unranked
0 citations

I‐Ju Yeh, Jon‐Luc Poirier, Edward A. Motea, Snehal B. Bhandare

Kub5‐Hera Deficiency Promotes R‐Loop‐Induced Genomic Instability and Carcinogenesis Following Whole‐Body Exposure to Ionizing Radiation

The FASEB Journal(2022)10.1096/fasebj.2022.36.s1.l6387
N/A
0DataRank · unranked
0 citations

Julio C. Morales, S. Louise Pay, Genevieve M. Crane, Edward A. Motea

NQO1-Bioactivatable Therapeutics as Radiosensitizers for Cancer Treatment

IntechOpen eBooks(2020)10.5772/intechopen.90205
N/A
0DataRank · unranked
1 citations

Edward A. Motea, Xiumei Huang, Colton L. Starcher, Jayne M. Silver, I‐Ju Yeh +6 more

Combined inhibition of Ref‐1 and STAT3 leads to synergistic tumour inhibition in multiple cancers using 3D and in vivo tumour co‐culture models

Journal of Cellular and Molecular Medicine(2020)10.1111/jcmm.16132
N/A
0DataRank · unranked
17 citations

Fenil Shah, Colton L. Starcher, Randall Wireman, Olivia Babb, Michelle Grimard +12 more